CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 27, 2006--Curis, Inc. (NASDAQ:CRIS - News), a therapeutic drug development company, today reported its financial results for the second quarter ended June 30, 2006. For the second quarter of 2006, Curis reported a net loss of $3,924,000, or ($0.08) per share, as compared to a net loss of $4,858,000 or ($0.10) per share for the same period in the prior year.
